Neurizon Therapeutics Limited (ASX:NUZ)

Neurizon Therapeutics Revenue

In the fiscal year ending June 30, 2026, Neurizon Therapeutics had annual revenue of 17.59M AUD with 1,043.54% growth. Neurizon Therapeutics had revenue of 11.61M in the half year ending June 30, 2026. That makes Neurizon Therapeutics the 36,355th largest company in the world by revenue and 646th in Australia.

• Revenue: 17.59M
• Revenue Growth: +1,043.54%
• P/S Ratio: 3.39
• Revenue / Employee: 4.40M
• Employees: 4
• Market Cap: 60.46M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	17.59M	16.05M	1,043.54%
Jun 30, 2025	1.54M	696.12K	82.70%
Jun 30, 2024	841.71K	-31.94K	-3.66%
Jun 30, 2023	873.65K	-3.64M	-80.63%
Jun 30, 2022	4.51M	853.24K	23.33%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error